Study on the Changes in Circadian Rhythm Before and After Treatment and the Influencing Factors in Patients with Depression
Ping Guo,Yu Fang,Min Feng,Yue Shen,Shengliang Yang,Shikai Wang,Mincai Qian
DOI: https://doi.org/10.2147/NDT.S384879
IF: 2.989
2022-11-11
Neuropsychiatric Disease and Treatment
Abstract:Ping Guo 1, 2 &ast, Yu Fang 1 &ast, Min Feng, 1 Yue Shen, 1 Shengliang Yang, 1 Shikai Wang, 1 Mincai Qian 1 1 Department of Psychosomatic Medicine, Huzhou Third Municipal Hospital, Huzhou, People's Republic of China; 2 Huzhou Third Municipal Hospital Affiliated with Huzhou University, Huzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shikai Wang; Mincai Qian, Department of Psychosomatic Medicine, Huzhou Third Municipal Hospital, No. 2088 in Tiaoxi East Road, Wuxing District, Huzhou, Zhejiang Province, 313000, People's Republic of China, Tel +86 13665752769 ; +86 13757289002, Email ; Objective: To investigate the circadian rhythms of patients with major depressive disorder (MDD) pre-treatment and post-treatment to analyse possible influencing factors. Methods: In this study, we recruited 154 patients in the acute phase of MDD from 10 psychiatric centers in the province. The patients were divided into a morning chronotype group (16– 41 points), an intermediate chronotype group (42– 58 points) and an evening chronotype group (59– 86 points), according to the total scores obtained from the morningness–eveningness questionnaire (MEQ). They were treated randomly with antidepressants, either selective serotonin reuptake inhibitors or agomelatine, for 12 weeks and were evaluated using the MEQ, the 17-item Hamilton Depression Rating Scale (HAMD-17), the Hamilton anxiety scale, the Snaith–Hamilton pleasure scale (SHAPS), the multidimensional fatigue inventory (MFI-20) and the Pittsburgh sleep quality index at the baseline and then at 2, 4, 8 and 12 weeks. The results were analysed by Logistic regression analysis and repeated-measures analysis of variance. Results: The baseline detection rates for the evening, intermediate and morning types were 14.93%, 56.5% and 28.57%, respectively. HAMD-17 scores were significantly lower at weeks 2, 4, 8, and 12 after treatment in patients with different concurrent phenotypes compared with those before treatment (P< 0.05). There were significant differences in gender, age, body mass index, whether depression was first-episode, type of medication, baseline-MEQ and baseline-SHAPS in the chronotype change group compared with the post-treatment chronotype unchanged group (p< 0.05). Logistic regression analysis showed that medication type (P=0.047), baseline MEQ (P=0.001) and baseline SHAPS (P=0.001) were risk factors for improvement in circadian rhythm after treatment for depression. Conclusion: Circadian rhythm disturbances can be adjusted to a normal pattern with effective antidepressant therapy. The medication type, baseline MEQ and baseline SHAPS scores were the influencing factors for the recovery of circadian rhythm disorders. Keywords: major depressive disorder, morningness–eveningness questionnaire, circadian rhythm, chronotype, antidepressant Depression is one of the most common psychiatric disorders and the leading cause of disability worldwide. The clinical features of depression mainly manifest as a significant and lasting loss of interest or emotional depression, accompanied by cognitive, behavioural, biological and somatic disorders. 1 Depression prevalence rates have ranged from 10–77%. 2 Although many researchers have shown that the pathogenesis is related to genetic, physiological or biological, it is difficult for antidepressants to be fully effective, and there is little progress in drug research. 3 In addition, there are several studies that focus on psychological factors in the pathogenesis of depression. 4 The primary drugs used in the treatment of depression are tricyclic antidepressants, monoamine oxidase inhibitors and selective serotonin reuptake inhibitors (SSRIs). 5 Sleep problems and depression are highly comorbid conditions. A large number of studies have shown that there are obvious sleep disturbances and abnormal circadian rhythms during major depressive episodes. 6 Circadian rhythm refers to physical, mental and behavioural changes throughout a 24-hour cycle, and it plays a central role in both mental and physical health. 7 It has been reported that disturbances in circadian rhythms could be a unique clinical manifestation of mood disorders, and phase shift of circadian rhythms can serve as a marker for mood disorders. 8 In recent years, there have been many hypotheses about the relationship between major depressive disorders and circadian rhythms. These hypotheses focus on the elaboration of the sleep process (slow-wave deficiency and slow-wave activity), the study of neurotransmitter systems (cholinergic and am -Abstract Truncated-
psychiatry,clinical neurology